Navidea Biopharmaceuticals
Presence
Navidea Biopharmaceuticals is a company listed under the stock ticker NAVB (US).
Executives
View the org chart displaying its 7 main executives
Most searched biographies at Navidea Biopharmaceuticals
Popular executive movements at Navidea Biopharmaceuticals
- Craig Dais has joined the company as Chief Financial Officer (posted on July 28 2023).
Create your alert
to follow the executive moves at Navidea Biopharmaceuticals.
Pharmaceuticals
Navidea Biopharmaceuticals has 1,861 competitors including Pfizer (United States (USA)), Sanofi (France) and Johnson & Johnson (United States (USA)).
Popular M&A news in Pharmaceuticals
- MedMen has filed for bankruptcy protection (posted on April 28 2024).
- AstraZeneca has announced the acquisition of Fusion Pharma (posted on March 23 2024).
- AstraZeneca has announced the acquisition of Amolyt Pharma (posted on March 19 2024).
Popular contacts in Pharmaceuticals
News
Press releases by Navidea Biopharmaceuticals
- Navidea Biopharmaceuticals, Inc. Files Form 15 to Voluntarily Deregister and Suspend its SEC Reporting Obligations :: Navidea Biopharmaceuticals, Inc. (NAVB)
- Navidea Biopharmaceuticals, Inc. and Capital Royalty Partners II, L.P. Enter Binding Settlement Agreement and Mutual Release :: Navidea Biopharmaceuticals, Inc. (NAVB)
- Navidea Biopharmaceuticals, Inc. Announces NYSE American’s Decision to Suspend Trading In Its Common Stock :: Navidea Biopharmaceuticals, Inc. (NAVB)
- Navidea Biopharmaceuticals, Inc. NAVB Requests Oral Hearing With NYSE Hearing Panel :: Navidea Biopharmaceuticals, Inc. (NAVB)
- Navidea Biopharmaceuticals, Inc. Hires Craig A. Dais, CPA as Chief Financial Officer :: Navidea Biopharmaceuticals, Inc. (NAVB)
- Navidea Biopharmaceuticals, Inc. Announces NYSE American Has Commenced Delisting Proceedings and Intent to Appeal NYSE American Determination :: Navidea Biopharmaceuticals, Inc. (NAVB)
- Navidea Biopharmaceuticals, Inc. Presses Ahead, Embraces Opportunities :: Navidea Biopharmaceuticals, Inc. (NAVB)
- Press Releases :: Navidea Biopharmaceuticals, Inc. (NAVB)
- Navidea Biopharmaceuticals, Inc. Welcomes Dana J Moss, JD to Board of Directors; Amit Bhalla Steps Down :: Navidea Biopharmaceuticals, Inc. (NAVB)
- Navidea Biopharmaceuticals, Inc. Rejects Unsolicited Offer To Acquire Certain Assets :: Navidea Biopharmaceuticals, Inc. (NAVB)
- View more press releases Close
Social media about Navidea Biopharmaceuticals
- Navidea Biopharmaceuticals on Wikipedia, Google News & Yahoo Finance
- Navidea Biopharmaceuticals on LinkedIn, Twitter & YouTube
Get in Touch
Contact by email its executives including Alexander Cappello 
Call Navidea Biopharmaceuticals at +1 614...
